BioCentury
ARTICLE | Company News

Management tracks

March 27, 2015 12:50 AM UTC

Jeffrey Yordon retired as chairman and CEO of specialty pharma Sagent Pharmaceuticals Inc. (NASDAQ:SGNT). Also, President James Hussey is departing. Yordon will remain a director. Board member Frank Kung will become chairman, and an executive management committee is leading the company while the board searches for a new CEO. Sagent shed $2.43 to $23.95 on Thursday. ...